American Society of Hematology

ASH is the leader in representing the interests of scientists and clinicians working in the field of hematology on Capitol Hill and within federal agencies concerned with the study and treatment of blood-related diseases.

View all action alerts
  • What Hematologists Need to Know About Alternative Payment Models in Medicare Part II

    A second look at the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA).  ASH previously examined the new Merit-Based Incentive Payment System and what it means for hematologists.  MACRA also offers an alternative path for physicians to participate in “alternative payment models”.  ASH explores what models might qualify as “alternative” and how hematologists may be able to participate.   

  • ASH 2015 Highlights New Payment Models and Performance Measurement

    The 2015 ASH Quality Symposium and the 2015 ASH Practice Partnership lunch addressed two sides of the issue of how hematologists can demonstrate their value and get paid for providing it.

  • ASH Report from the AMA House of Delegates

    The ASH Delegation has returned from the interim meeting of the American Medical Meeting House of Delegates. Working with the AMA has enabled ASH to influence many policies and special access to influential advisory groups.

  • What Hematologist Need to Know about the Medicare Merit-based Incentive Payment System

    In April, 2015, the Medicare Access and CHIP Reauthorization (MACRA) was signed into law. The headline at the time of passage was the end of the Sustainable Growth Rate (SGR) formula that had for so many years mandated large annual Medicare payment cuts to physicians. MACRA did not just affect the overall payment mechanism – it also created a new pay for performance system for physicians. Many of these elements are similar or identical to the existing pay-for-performance program in Medicare but we will highlight some of the differences.

View all policy news
back to top